SPT Labtech designs and manufactures robust, reliable and easy-to-use solutions for liquid handling, sample preparation and management, plus cryo-EM. We enable life scientists through collaboration, deep application knowledge and leading engineering to accelerate research and make a difference together. Our essential tools include state-of-the-art solutions developed for:
- unique low-volume liquid handling for genomics, compound screening and protein crystallography (mosquito® X1, mosquito® HTS, mosquito® crystal, mosquito® LCP, mosquito® HV, dragonfly® crystal, dragonfly® discovery and a full range of validated consumables such as tips and plates).
- flexible sample management workflows from ambient to -80°C (arktic®, arktic® XC, comPOUND®, lab2lab)
- cryo-EM enabling technology (chameleon).
SPT Labtech was formerly TTP Labtech
- unique low-volume liquid handling for genomics, compound screening and protein crystallography (mosquito® X1, mosquito® HTS, mosquito® crystal, mosquito® LCP, mosquito® HV, dragonfly® crystal, dragonfly® discovery and a full range of validated consumables such as tips and plates).
- flexible sample management workflows from ambient to -80°C (arktic®, arktic® XC, comPOUND®, lab2lab)
- cryo-EM enabling technology (chameleon).
SPT Labtech was formerly TTP Labtech
Location: United Kingdom, England, South Cambridgeshire
Employees: 201-500
Founded date: 2001
Mentions in press and media 20
| Date | Title | Description |
| 24.05.2026 | Blank Bio Ignites Precision Oncology with $7.2M Seed Round | Blank Bio secured $7.2M in seed funding. This investment propels RNA foundation models for precision oncology. A strategic partnership with PacBio will generate critical high-resolution long-read RNA sequencing data from patient tumors. Bla... |
| 21.05.2026 | Blank Bio: $7.2 Million Seed Raised To Advance RNA Foundation Models For Precision Oncology | Blank Bio announced the closing of a $7.2 million seed financing alongside a strategic collaboration with PacBio to advance RNA foundation models for precision oncology applications. The San Francisco-based company is building foundation mo... |
| 19.05.2026 | Blank Bio: $7.2 Million Seed Financing Raised To Advance RNA Foundation Models For Precision Oncology | Blank Bio, an applied AI research lab focused on training foundation models for RNA, announced the closing of a $7.2 million seed financing round along with a strategic collaboration with Pacific Biosciences to advance RNA foundation models... |
| 02.04.2026 | Semarion Secures $3.8M to Propel Cell Assay Technology in Drug Discovery | Semarion, a pioneering Cambridge biotech firm, successfully raised $3.8 million. This strategic funding fuels the company's aggressive commercial expansion plans. It scales manufacturing of its groundbreaking SemaCyte platform. SemaCyte rev... |
| 01.04.2026 | Semarion: University of Cambridge Spin-Out Raises $3.8 Million To Scale Cell Assay Technology For Drug Discovery | Semarion, a University of Cambridge spin-out focused on advancing cell-based research, announced it has raised $3.8 million to expand its next-generation cell assay technology and accelerate adoption across the pharmaceutical industry. The ... |
| 21.02.2024 | SPT Labtech continues to support UKHSA genomics surveillance project to bolster global health security | Cambridge – SPT Labtech, a global leader in the design, development and manufacture of automated instrumentation and consumables for life science applications, continues its partnership with the UK Health Security Agency (UKHSA) to advance ... |
| 02.11.2023 | SPT Labtech launches firefly® for LDT to streamline liquid handling in NGS-based Laboratory Developed Tests | New software features and enhancements have been designed to support the rigorous and expanding needs of clinical laboratories Cambridge, UK – SPT Labtech, a global leader in the design, development and manufacture of automated instrumentat... |
| 23.06.2022 | EQT buys SPT Labtech for £650 million to speed up life science research | UK-based genomics laboratory automation startup, SPT Labtech has been acquired by EQT from Battery Ventures for £650 million. The automation of research, miniaturisation trends, and broader adoption of multi-omics will support SPT’s core li... |
| 23.06.2022 | Startups and VCs should be preparing for the possibility of stagflation | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. The last time stagflation hit the U.S., “startup” was a niche term, VC an obscure cottage industr... |
| 22.06.2022 | EQT Private Equity to acquire SPT Labtech, a fast-growing laboratory automation player focused on low-volume liquid handling technology for GBP 650 million from Battery Ventures | EQT Private Equity to acquire SPT Labtech, a fast-growing laboratory automation player focused on low-volume liquid handling technology for GBP 650 million from Battery Ventures Wed, Jun 22, 2022 08:00 CET Report this content EQT Private Eq... |
Show more